Marlborough biotech firm Advanced Cell Technology said it has picked up $30 million in capital through a common stock purchase agreement with a Chicago-based investment firm. The deal, with Lincoln ...

WASHINGTON (KRT) ­ A Massachusetts company said Sunday that it had for the first time cloned an early human embryo in an experiment intended to eventually produce matching cells for patients with a ...

View post: Qualcomm’s massive AI expansion already has 2 Mag 7 giants on board ...

WASHINGTON, Nov 22 (Reuters) - Massachusetts-based Advanced Cell Technology said the U.S. Food and Drug Administration approved a clinical trial of its human embryonic stem cell treatment for a ...

Ocata Therapeutics of Marlborough, which researches treatments for eye diseases, has agreed to be sold to Astellas Pharma Inc. of Japan for $379 million, the two companies announced late Monday.